DIAMEDICA THERAPEUTICS INC shareholders Q4 2022

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 28 filers reported holding DIAMEDICA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.

DIAMEDICA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 233,730$369,2930.45%
COOPERMAN LEON G 812,508$1,283,8440.08%
CATALYST FINANCIAL PARTNERS LLC 14,475$22,8720.01%
Legend Financial Advisors, Inc. 1,000$1,5800.00%
GEODE CAPITAL MANAGEMENT, LLC 184,870$2920.00%
STATE STREET CORP 133,258$210,5480.00%
MORGAN STANLEY 55,201$87,2230.00%
BlackRock Inc. 69,937$110,5080.00%
Bank of New York Mellon Corp 36,062$56,9820.00%
Citadel Advisors 1,600$2,5280.00%
Citadel Advisors 100$1580.00%
Citadel Advisors 39,216$61,9610.00%
SIMPLEX TRADING, LLC 4,563$70.00%
Tower Research Capital LLC (TRC) 3,684$60.00%
Renaissance Technologies 33,619$530.00%
TD Waterhouse Canada Inc. 1,570$2,9060.00%
ROYAL BANK OF CANADA 805$1,0000.00%
VANGUARD GROUP INC 782,989$1,237,2010.00%
Advisory Services Network, LLC 1,500$2,3700.00%
JANE STREET GROUP, LLC 20,840$32,9290.00%
External links

This page lists DIAMEDICA THERAPEUTICS INC's shareholders in Q4 2022. To view DIAMEDICA THERAPEUTICS INC's shareholder history, click here.